Communications and Investor Relations

Andrea Gilpin
Vice President, IR & Communications
Telephone: 514 336-7800, ext. 205
communications@theratech.com

Emails forwarded to the Investor Relations Department will be answered by phone only. For this reason, please provide your telephone number so that we may reach you.

Business development

Theratechnologies seeks to form strategic alliances that will maximize the value of its products.

We are currently seeking partners for the following out-licencing candidate:

• Glaucoma

For additional information:

Claude Larose
Director, Business Development
Telephone: 514 336-7800, ext. 223
businessdev@theratech.com

Human resources (job offerings)

If you wish to join this exciting and dynamic team and play an active role in Theratechnologies’ success, please contact us by email at the following address: cv@theratech.com

Although each application is taken into consideration, only selected candidates will be contacted. We are an equal opportunity employer.

Clinical trials

For any question concerning our Phase 3 clinical trial in HIV-associated lipodystrophy, please write to us at the following address: thelipostudy@theratech.com

For any question related to our other clinical trials, please contact:

Christian Marsolais
Vice President, Clinical Research
Telephone: 514 336-7800, ext. 217
etudescliniques@theratech.com